NO951444D0 - Gestagent aktive 19,11-broede 4-östrener - Google Patents

Gestagent aktive 19,11-broede 4-östrener

Info

Publication number: NO951444D0
Authority: NO; Norway
Prior art keywords: ostrener; gestagent; breed; active; production
Prior art date: 1992-10-13

Application number

NO951444A

Other languages

English (en)

Other versions

NO951444L (no

NO305440B1 (no

Inventor

Eckhard Ottow

Wolfgang Schwede

Wolfgang Halfbrodt

Karl-Heinrich Fritzemeier

Rolf Krattenmacher

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-13

Filing date

1995-04-12

Publication date

1995-04-12

1995-04-12 Application filed by Schering Ag filed Critical Schering Ag

1995-04-12 Publication of NO951444D0 publication Critical patent/NO951444D0/no

1995-06-13 Publication of NO951444L publication Critical patent/NO951444L/no

1999-05-31 Publication of NO305440B1 publication Critical patent/NO305440B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Absorbent Articles And Supports Therefor (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Eye Examination Apparatus (AREA)
Ultra Sonic Daignosis Equipment (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Glass Compositions (AREA)
Toys (AREA)
Superconductors And Manufacturing Methods Therefor (AREA)
Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)

NO951444A 1992-10-13 1995-04-12 Gestagent aktive 19,11-broede 4-°strener NO305440B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4235220A DE4235220A1 (de)	1992-10-13	1992-10-13	Gestagen wirksame 19,11ß-überbrückte 4-Estrene
PCT/EP1993/002823 WO1994009025A1 (de)	1992-10-13	1993-10-13	Gestagen wirksame 19,11-überbrückte 4-estrene

Publications (3)

Publication Number	Publication Date
NO951444D0 true NO951444D0 (no)	1995-04-12
NO951444L NO951444L (no)	1995-06-13
NO305440B1 NO305440B1 (no)	1999-05-31

Family

ID=6470806

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO951444A NO305440B1 (no)	1992-10-13	1995-04-12	Gestagent aktive 19,11-broede 4-°strener

Country Status (25)

Country	Link
US (2)	US5523298A (no)
EP (1)	EP0664811B1 (no)
JP (1)	JP3302366B2 (no)
KR (1)	KR100341066B1 (no)
CN (1)	CN1052238C (no)
AT (1)	ATE156837T1 (no)
AU (1)	AU677019B2 (no)
BR (1)	BR9307232A (no)
CA (1)	CA2146962A1 (no)
CZ (1)	CZ284187B6 (no)
DE (2)	DE4235220A1 (no)
DK (1)	DK0664811T3 (no)
ES (1)	ES2108298T3 (no)
FI (1)	FI951760A7 (no)
GR (1)	GR3024940T3 (no)
HU (1)	HU223315B1 (no)
IL (1)	IL107232A (no)
NO (1)	NO305440B1 (no)
NZ (1)	NZ256865A (no)
PL (1)	PL179764B1 (no)
RU (1)	RU2157814C2 (no)
SK (1)	SK280991B6 (no)
TW (1)	TW341575B (no)
WO (1)	WO1994009025A1 (no)
ZA (1)	ZA937614B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4235220A1 (de) *	1992-10-13	1994-06-16	Schering Ag	Gestagen wirksame 19,11ß-überbrückte 4-Estrene
DE4413184A1 (de) *	1994-04-12	1995-10-19	Schering Ag	10,11-C¶3¶-überbrückte Steroide
DE4413185A1 (de) *	1994-04-12	1995-10-19	Schering Ag	11beta,19-überbrückte 13alpha-Alkylsteroide
US5912006A (en) *	1996-08-28	1999-06-15	Eboc, Inc.	Compositions and methods for alleviating discomforting menstrual pain
JP2004516841A (ja) *	2000-12-28	2004-06-10	シエーリングアクチエンゲゼルシャフト	プロゲステロンレセプターアイソフォーム特異的リガンドおよび組織選択的プロゲステロンレセプターリガンドについてスクリーニングする方法
US20040121304A1 (en) *	2001-12-21	2004-06-24	Ulrike Fuhrmann	Method for screening for progesterone receptor isoform-specific ligands and for tissue-selective progesterone receptor ligands
GB0219345D0 (en) *	2002-08-20	2002-09-25	Givaudan Sa	Improvements in or relating to organic compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU139639A1 (ru) *	1960-03-28	1960-11-30	Н.В. Маревич	Крепь дл поддержани междуэтажных целиков при щитовой системе разработки
US3465010A (en) *	1966-11-22	1969-09-02	Searle & Co	17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US4361559A (en) *	1981-08-20	1982-11-30	E. R. Squibb & Sons, Inc.	Antiinflammatory 17,17-bis (substituted thio) androstenes
US5446178A (en) *	1987-03-18	1995-08-29	Schering Aktiengesellschaft	Process for preparing 19,11β-bridged steroids
DE3708942A1 (de) *	1987-03-18	1988-09-29	Schering Ag	19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3717169A1 (de) *	1987-05-19	1988-12-01	Schering Ag	19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3832303A1 (de) *	1988-09-20	1990-04-12	Schering Ag	11ss-phenyl-14ssh-steroide
DE3917274A1 (de) *	1989-05-24	1990-11-29	Schering Ag	9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4038128A1 (de) *	1990-11-27	1992-06-04	Schering Ag	8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4235220A1 (de) *	1992-10-13	1994-06-16	Schering Ag	Gestagen wirksame 19,11ß-überbrückte 4-Estrene

1992
- 1992-10-13 DE DE4235220A patent/DE4235220A1/de not_active Withdrawn
1993
- 1993-10-11 IL IL107232A patent/IL107232A/en not_active IP Right Cessation
- 1993-10-12 CN CN93114844A patent/CN1052238C/zh not_active Expired - Fee Related
- 1993-10-13 ES ES93922949T patent/ES2108298T3/es not_active Expired - Lifetime
- 1993-10-13 ZA ZA937614A patent/ZA937614B/xx unknown
- 1993-10-13 FI FI951760A patent/FI951760A7/fi unknown
- 1993-10-13 BR BR9307232A patent/BR9307232A/pt not_active Application Discontinuation
- 1993-10-13 AT AT93922949T patent/ATE156837T1/de not_active IP Right Cessation
- 1993-10-13 DK DK93922949.8T patent/DK0664811T3/da active
- 1993-10-13 SK SK494-95A patent/SK280991B6/sk unknown
- 1993-10-13 HU HU9501057A patent/HU223315B1/hu not_active IP Right Cessation
- 1993-10-13 JP JP50962494A patent/JP3302366B2/ja not_active Expired - Fee Related
- 1993-10-13 KR KR1019950701398A patent/KR100341066B1/ko not_active Expired - Fee Related
- 1993-10-13 EP EP93922949A patent/EP0664811B1/de not_active Expired - Lifetime
- 1993-10-13 US US08/135,486 patent/US5523298A/en not_active Expired - Lifetime
- 1993-10-13 WO PCT/EP1993/002823 patent/WO1994009025A1/de not_active Ceased
- 1993-10-13 CA CA002146962A patent/CA2146962A1/en not_active Abandoned
- 1993-10-13 RU RU95109891/04A patent/RU2157814C2/ru not_active IP Right Cessation
- 1993-10-13 CZ CZ95919A patent/CZ284187B6/cs not_active IP Right Cessation
- 1993-10-13 NZ NZ256865A patent/NZ256865A/en unknown
- 1993-10-13 AU AU51774/93A patent/AU677019B2/en not_active Ceased
- 1993-10-13 PL PL93308349A patent/PL179764B1/pl unknown
- 1993-10-13 DE DE59307133T patent/DE59307133D1/de not_active Expired - Fee Related
- 1993-10-28 TW TW082109012A patent/TW341575B/zh active
1995
- 1995-04-12 NO NO951444A patent/NO305440B1/no not_active IP Right Cessation
- 1995-06-07 US US08/484,318 patent/US5703066A/en not_active Expired - Fee Related
1997
- 1997-10-03 GR GR970402581T patent/GR3024940T3/el unknown

Also Published As

Publication number	Publication date
EP0664811B1 (de)	1997-08-13
EP0664811A1 (de)	1995-08-02
ZA937614B (en)	1994-05-23
HUT71523A (en)	1995-12-28
DE4235220A1 (de)	1994-06-16
US5523298A (en)	1996-06-04
CA2146962A1 (en)	1994-04-28
AU677019B2 (en)	1997-04-10
JPH08502276A (ja)	1996-03-12
RU2157814C2 (ru)	2000-10-20
KR950703576A (ko)	1995-09-20
ATE156837T1 (de)	1997-08-15
AU5177493A (en)	1994-05-09
KR100341066B1 (ko)	2002-12-06
SK280991B6 (sk)	2000-10-09
JP3302366B2 (ja)	2002-07-15
FI951760L (fi)	1995-04-12
IL107232A0 (en)	1994-01-25
CN1092428A (zh)	1994-09-21
NO951444L (no)	1995-06-13
FI951760A0 (fi)	1995-04-12
HU223315B1 (hu)	2004-05-28
NZ256865A (en)	1996-04-26
SK49495A3 (en)	1995-08-09
ES2108298T3 (es)	1997-12-16
RU95109891A (ru)	1997-02-10
US5703066A (en)	1997-12-30
FI951760A7 (fi)	1995-04-12
CZ91995A3 (en)	1995-09-13
NO305440B1 (no)	1999-05-31
TW341575B (en)	1998-10-01
WO1994009025A1 (de)	1994-04-28
DK0664811T3 (da)	1998-03-30
PL179764B1 (pl)	2000-10-31
CZ284187B6 (cs)	1998-09-16
GR3024940T3 (en)	1998-01-30
PL308349A1 (en)	1995-07-24
CN1052238C (zh)	2000-05-10
HU9501057D0 (en)	1995-06-28
BR9307232A (pt)	1999-08-24
IL107232A (en)	1998-06-15
DE59307133D1 (de)	1997-09-18

Publication	Publication Date	Title
WO1996032003A3 (en)	1997-01-03	Tetrahydroimidazopyridoindolediones and their use as medicaments
FI113644B (fi)	2004-05-31	Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
SE9504661D0 (sv)	1995-12-22	New compounds
DE59108530D1 (de)	1997-03-20	Antimikrobielle Mittel sowie substituierte 2-Cyclohexan-1-yl-amin-Derivate und deren Herstellung
BG103399A (en)	2000-01-31	New heterocycle-substituted benzamides and their application for the treatment of diseases
ES2153975T3 (es)	2001-03-16	Derivados de pirimidona con actividad antifungica.
DE69615682D1 (de)	2001-11-08	N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
IL119207A0 (en)	1996-12-05	Treatment of tinnitus using neuroprotective agents
MX9305248A (es)	1995-01-31	Compuestos de diarilpiperazinoacetamida.
DE69626981D1 (de)	2003-04-30	N-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
ATE196899T1 (de)	2000-10-15	N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5- benzodiazepin-3-yl)-3-amide
CA2094806A1 (en)	1992-05-08	Aminosulfonyl urea acat inhibitors
NO951444D0 (no)	1995-04-12	Gestagent aktive 19,11-broede 4-östrener
DE69627344D1 (de)	2003-05-15	N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
TW252979B (no)	1995-08-01
TR200000291T2 (tr)	2000-07-21	Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
ES2104509A1 (es)	1997-10-01	Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
SE9504662D0 (sv)	1995-12-22	New compounds
IT1255461B (it)	1995-11-02	Eteri di imidazoli ad attivita' a ii antagonista
ATE80629T1 (de)	1992-10-15	Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln.

Legal Events

Date	Code	Title	Description
2004-10-11	MM1K	Lapsed by not paying the annual fees